title: Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.
abstract: Molecular studies have shown that the majority of azole resistance in Aspergillus fumigatus is associated with amino acid substitutions in the cyp51A gene. To obtain insight into azole resistance mutations, the cyp51A gene of 130 resistant and 76 susceptible A. fumigatus isolates was sequenced. Out of 130 azole-resistant isolates, 105 contained a tandem repeat of 34 bp in the promoter region and a leucine-to-histidine substitution in codon 98 (designated TR/L98H). Additionally, in 12 of these TR/L98H resistant isolates, the mutations S297T and F495I were found, and in 1 isolate, the mutation F495I was found. In eight azole-resistant isolates, known azole resistance mutations were detected in codon G54, G138, or M220. In three azole-susceptible isolates, the mutation E130D, L252L, or S400I was found and in 13 azole-susceptible isolates but also in 1 azole-resistant isolate, the mutations F46Y, G98G, M172V, N248T, D255E, L358L, E427K, and C454C were found. All of the nonsynonymous mutations, apart from the mutations in codons G54, G138, and M220 and L98H, were located at the periphery of the protein, as determined by a structural model of the A. fumigatus Cyp51A protein, and were predicted neither to interact with azole compounds nor to affect structural integrity. Therefore, this wide diversity of mutations in the cyp51A gene in azole-susceptible A. fumigatus isolates is not correlated with azole resistance. Based on the Cyp51A protein homology model, the potential correlation of a mutation to azole resistance can be predicted.
authors.affiliation: Radboud University Nijmegen Medical Center, Antonie van Leeuwenhoeklaan, Nijmegen HB, The Netherlands. e.snelders@mmb.umcn.nl
authors.forename: Eveline
authors.initials: E
authors.lastname: Snelders
authors.forename: Anna
authors.initials: A
authors.lastname: Karawajczyk
authors.forename: Gijs
authors.initials: G
authors.lastname: Schaftenaar
authors.forename: Paul E
authors.initials: PE
authors.lastname: Verweij
authors.forename: Willem J G
authors.initials: WJ
authors.lastname: Melchers
mesh_terms: D019943:Amino Acid Substitution; D000935:Antifungal Agents / Q000494:pharmacology*; D001232:Aspergillus fumigatus / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics*; D001393:Azoles / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000737:chemistry* / Q000235:genetics*; D025141:Drug Resistance, Fungal / Q000235:genetics; D005656:Fungal Proteins / Q000737:chemistry* / Q000235:genetics*; D005800:Genes, Fungal; D006801:Humans; D066298:In Vitro Techniques; D008958:Models, Molecular; D020125:Mutation, Missense; D011487:Protein Conformation; D040681:Structural Homology, Protein; D020080:Tandem Repeat Sequences
chemical_list: D000935:Antifungal Agents; D001393:Azoles; D005656:Fungal Proteins; D003577:Cytochrome P-450 Enzyme System; C465526:cytochrome P-450 CYP51A, Aspergillus
references.citation: Drug Resist Updat. 2009 Dec;12(6):141-7
references.pmid: 19879181
references.citation: Antimicrob Agents Chemother. 2004 Jul;48(7):2747-50
references.pmid: 15215142
references.citation: Emerg Infect Dis. 2009 Jul;15(7):1068-76
references.pmid: 19624922
references.citation: Pharmacol Ther. 1995;67(1):79-100
references.pmid: 7494862
references.citation: J Mol Graph. 1996 Feb;14(1):33-8, 27-8
references.pmid: 8744570
references.citation: Nat Rev Genet. 2007 Mar;8(3):206-16
references.pmid: 17304246
references.citation: Antimicrob Agents Chemother. 2004 Feb;48(2):568-74
references.pmid: 14742211
references.citation: Antimicrob Agents Chemother. 2009 Aug;53(8):3487-95
references.pmid: 19470512
references.citation: Lancet. 2007 Jul 7;370(9581):102
references.pmid: 17617278
references.citation: Bioorg Med Chem. 2004 Jun 1;12(11):2937-50
references.pmid: 15142553
references.citation: Future Microbiol. 2006 Oct;1(3):283-93
references.pmid: 17661641
references.citation: FEMS Microbiol Lett. 2007 Dec;277(1):37-43
references.pmid: 17986082
references.citation: J Gen Virol. 2006 Jan;87(Pt 1):103-113
references.pmid: 16361422
references.citation: N Engl J Med. 2007 Apr 5;356(14):1481-3
references.pmid: 17409336
references.citation: Med Mycol. 2010 Feb;48(1):197-200
references.pmid: 20055745
references.citation: Antimicrob Agents Chemother. 2003 Mar;47(3):1120-4
references.pmid: 12604551
references.citation: Clin Microbiol Rev. 2009 Apr;22(2):291-321, Table of Contents
references.pmid: 19366916
references.citation: Antimicrob Agents Chemother. 2008 Jul;52(7):2468-72
references.pmid: 18474574
references.citation: Biochem Biophys Res Commun. 2005 Dec 9;338(1):418-22
references.pmid: 16153595
references.citation: Appl Environ Microbiol. 2009 Jun;75(12):4053-7
references.pmid: 19376899
references.citation: Fungal Genet Biol. 2002 Aug;36(3):199-206
references.pmid: 12135575
references.citation: Int J Antimicrob Agents. 2006 Nov;28(5):450-3
references.pmid: 17034993
references.citation: Antimicrob Agents Chemother. 2007 Jun;51(6):1897-904
references.pmid: 17371828
references.citation: PLoS Med. 2008 Nov 11;5(11):e219
references.pmid: 18998768
references.citation: Med Mycol. 2005 May;43 Suppl 1:S313-9
references.pmid: 16110826
references.citation: J Enzyme Inhib. 1999;14(3):175-92
references.pmid: 10445042